PHIBRO ANIMAL HEALTH CORP (PAHC) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US71742Q1067
PHIBRO ANIMAL HEALTH CORP financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 1.30 bn USD | 1.52 bn USD |
| Gross profit | 399.94 m USD | 512.52 m USD |
| Operating income | 110.47 m USD | 194.40 m USD |
| EBIT | 105.22 m USD | 183.76 m USD |
| Net income | 48.26 m USD | 99.72 m USD |
| Diluted EPS – continuing operations | 1.19 USD | 2.43 USD |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PHIBRO ANIMAL HEALTH CORP
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
More stocks
- Exzeo Group, Inc. (XZO)
- Lu-Ve SpA (LUVE.MI)
- Solar Applied Materials Technology (1785.TWO)
- Ruentex Engineering & Construction Co Ltd (2597.TW)
- Bandwidth Inc. (BAND)
- PATHWARD FINANCIAL, INC. (CASH)
- OVS SpA (OVS.MI)
- Taihan Fiber Optics Co. Ltd (010170.KQ)
- Cogeco Communications Inc (CCA.TO)
- Nexa Resources SA (NEXA)
- ICHOR HOLDINGS, LTD. (ICHR)
- Edinburgh Investment Trust PLC (EDIN.L)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.